Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
[The possibility of using music therapy in neurology on the example of multiple sclerosis].
Comment on "Fingolimod effects on left ventricular function in multiple sclerosis" Mult Scler 2015.
Low dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β.
Measuring longitudinal myelin water fraction in new multiple sclerosis lesions.
Cognitive and psychiatric comorbidities in neuromyelitis optica.
Oral fingolimod to treat multiple sclerosis: see your cardiologist first.
Serum proteomics in multiple sclerosis disease progression.
Natalizumab (TYSABRI) and multiple sclerosis. With longer follow-up: even more toxic than suspected.
Control of Macrophage Dynamics as A Potential Therapeutic Approach for Clinical Disorders Involving Chronic Inflammation.
The pathological and physiological roles of IL-6 amplifier activation.
17β-estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions.
Retinal Layer Segmentation in Patients with Multiple Sclerosis Using Spectral Domain Optical Coherence Tomography.
Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis - insights into possible drug mechanism.
Efficacy and safety of alemtuzumab in multiple sclerosis and impact on nursing role.
Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.
Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.
Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method.
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation.
Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.
Neuronal Hemoglobin Expression and Its Relevance to Multiple Sclerosis Neuropathology.
Spinal anesthesia for cesarean delivery in a woman with neuromyelitis optica.
Functional connectivity underlying postural motor adaptation in people with multiple sclerosis.
Pages
« first
‹ previous
…
590
591
592
593
594
595
596
597
598
…
next ›
last »